Form D · Biotechnology
ROVERMED BIOSCIENCES, LLC
St Cloud, MN · CIK 0001715383
Offering snapshot reported Feb 14, 2018 · SEC filing
- Reported sold
- $1.2M Offering amount: $1.5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 26, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2018 | Initial | $1,200,003 | No comparison | 6 | SEC filing |
| Aug 25, 2017 | Initial | $761,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b, 4a5
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-305685
Series A Convertible Preferred Units
Source: Form D, filed Feb 14, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shaun Andrikopoulos | Director |
| Laura M Brod | Director, Executive |
| Tom Burke | Director |
| Inc. Genesegues | Promoter |
| Frank Manzella | Director |
| Sheila Mikhail | Director |
| Robert T. Unger | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3051 2 Nd Street South
St Cloud, MN, 56301
St Cloud, MN, 56301